Yuval Cohen

Insider Reports History

Location
C/O Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood, MA
Signature
/s/Yuval Cohen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yuval Cohen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Corbus Pharmaceuticals Holdings, Inc. Chief Executive Officer, Director Common Stock, par value $0.0001 per share 138K $2.37M $17.14 Oct 27, 2025 Direct
Corbus Pharmaceuticals Holdings, Inc. Chief Executive Officer, Director Stock options (right to buy) 22.1K Oct 27, 2025 Direct

Insider Reports Filed by Yuval Cohen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRBP Corbus Pharmaceuticals Holdings, Inc. Oct 24, 2025 6 -$353K 4 Oct 27, 2025 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Feb 14, 2025 1 -$62.5K 4 Feb 18, 2025 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Jan 31, 2025 2 $0 4 Feb 4, 2025 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Jun 14, 2024 22 -$1.99M 4 Jun 18, 2024 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Feb 12, 2024 2 $0 4 Feb 14, 2024 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Jan 26, 2024 2 $0 4 Jan 30, 2024 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Aug 10, 2022 1 $1K 4 Aug 11, 2022 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 16, 2022 1 $2.63K 4 May 16, 2022 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Mar 9, 2022 1 $3.18K 4 Mar 9, 2022 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Feb 13, 2022 1 $0 4 Feb 15, 2023 Chief Executive Officer, Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Chief Executive Officer, Director